Semble, a health tech startup, secures £11.6m with backing from Octopus and Mercia, aiming for global expansion.
- The company focuses on replacing outdated medical technology with its innovative clinical system.
- Inefficient IT systems in England’s healthcare cost over 13 million working hours annually, a problem Semble addresses.
- Semble’s platform supports automation, secure data exchange, and third-party integration, promising enhanced healthcare connectivity.
- Founders Christoph Lippuner and Mikael Landau lead the charge towards AI-driven healthcare solutions.
London-based health tech company Semble has successfully raised £11.6 million in a Series B funding round, supported by Octopus Ventures and Mercia Ventures. The firm, which aims to revolutionise healthcare technology, plans to utilise this investment for expansion into international markets.
Semble has developed a clinical platform designed to supplant outdated IT systems that hinder efficiency among medical providers. Recently, the British Medical Association highlighted how such inefficiencies in England cause doctors to lose over 13 million working hours each year.
The platform developed by Semble offers solutions through enhanced automation of healthcare tasks, secure exchanges of patient information, and integration with various third-party systems. This positions Semble as a leader in fostering a connected and efficient healthcare environment.
Co-founder Christoph Lippuner remarked on the importance of modernising healthcare technology, stating that for too long healthcare professionals have been distracted by outdated systems. The company’s mission centres on empowering healthcare workers to focus more on patient care rather than administrative burdens.
Founded by Christoph Lippuner and Mikael Landau in 2018, Semble has grown considerably since its early days. The entrepreneurs previously founded Orogo, which was sold to Just Eat, providing them with the experience and insight necessary to drive Semble forward in an evolving health tech market.
The recent funding round was spearheaded by Mercia Ventures, with additional investments from Smedvig Ventures and Triple Point. This shows significant confidence in Semble’s potential to reshape the healthcare landscape.
Alex Gwyther of Mercia Ventures underscored the urgency for healthcare to move past reliance on legacy systems, acknowledging the vast market opportunity available. Semble’s total funding now stands at $27 million, reflecting its steady growth and appeal to investors.
Semble’s innovative approach to healthcare technology positions it well for future growth and impact.
